Risparmio energetico

Questa schermata consente al tuo monitor di risparmiare energia. Clicca ovunque per tornare alla navigazione.

Kedrion SpA

5 July 2012

€ 100 mln

25.1%

Kedrion SpA
Kedrion SpA

Sector: plasma derivatives

Kedrion is a leading Italian operator and in 5th place worldwide in the sector of plasma derivatives, pharmaceuticals developed from proteins extracted from human plasma and used to cure coagulation disorders, infectious diseases, primary immunodeficiency disorders and neuropathologies, and in other areas of treatment.

Cdp Equity investment and objective

Project for the creation of a leading operator in the sector via growth abroad, both systematic and via acquisitions.

Cdp Equity’s investment has made it possible to acquire an American division of the Johnson&Johnson group active in the production of the medicine under the RhoGAM® brand.